Roche Halts Trials of Diabetes Drug on Safety Concern

Roche Holding AG halted testing of its most-advanced experimental diabetes drug over safety concerns and said it’s reassessing its research and development program for heart and metabolic diseases.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.